CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Neurocrine Biosciences against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods For Treating Testicular And Ovarian Adrenal Rest TumorsSPRUCE BIOSCIENCESDec 10, 2024

Explore Neurocrine Biosciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 12, 2024Crf1 Receptor Antagonists For The Treatment Of Congenital Adrenal Hyperplasia1

Top competitors of Neurocrine Biosciences

List of top competitors of Neurocrine Biosciences based on patent oppositions.